Modified natural cycle IVF and mild IVF: a 10 year Swedish experience
Abstract
Modified natural cycle IVF (mnc-IVF) or mild IVF (m-IVF) was offered to selected patients between 1996 and 2007; 43 patients during 129 cycles were treated with mnc-IVF and 145 couples during 250 cycles were treated with m-IVF. Comparison with outcome from conventional IVF cycles during the same time period and in the same clinic was performed. Although 53.5 and 39.6% of started cycles respectively never reached embryo transfer, the ongoing pregnancy rates per embryo transfer were 26.7% for mnc-IVF and 27.2% for m-IVF. During the same time period, cancellation rate for conventional IVF was 13.7% and the ongoing pregnancy rate per embryo transfer was 34.3%. For patients
38
years of age, the ongoing pregnancy rate per embryo transfer was 17.5% in the m-IVF group. None of the patients aged
38
years in the mnc-IVF group achieved an ongoing pregnancy. For patients treated with conventional IVF, the
38
years of age pregnancy rate per embryo transfer was 27.0%. Costs of medication for m-IVF and mnc-IVF were 96.3 and 97.5% less than for the least expensive conventional IVF cycle respectively. Pregnancy rates per embryo transfer are acceptable for these treatment modalities, the cost for medication is low, risks for complications are dramatically reduced, and the treatments may be more psychologically acceptable to the patients.
Keywords: clomiphene citrate, low cost IVF, mild IVF, modified natural cycle IVF, natural cycle
To access this article, please choose from the options below
Dr Aanesen completed his studies in medicine in 1990 at the Faculty of Medicine, University of Oslo, Norway. After his internship, he started his residency at the Department of Gynaecology and Obstetrics, Karolinska Hospital, Sweden, Stockholm in 1992, and became a specialist in 1997. He has had a research interest in sperm physiology and andrology and received his PhD 1998. Since 2001, Dr Aanesen has been working at the IVF Unit, Queen Sophia Hospital. His present research focuses on intracellular signalling and mild IVF.
PII: S1472-6483(09)00160-6
doi:10.1016/j.rbmo.2009.10.017
© 2009 Reproductive Healthcare Ltd. Published by Elsevier Inc All rights reserved.
